{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:40:52Z","timestamp":1765806052465,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T00:00:00Z","timestamp":1678924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>A 38-year-old transgender man with advanced metastatic functional pancreatic neuroendocrine neoplasm (PanNEN) gastrinoma was admitted to the Department of Endocrinology due to severe ACTH-dependent hypercortisolemia. An ectopic production of ACTH by PanNEN was suspected. The patient qualified for bilateral adrenalectomy after preoperative treatment with metyrapone. Finally, the patient underwent resection of the left adrenal gland with the tumor only, which surprisingly resulted in a significant decrease in ACTH and cortisol levels, leading to clinical improvement. Pathology report revealed an adenoma of the adrenal cortex with positive ACTH staining. The result of the simultaneous liver lesion biopsy confirmed a metastatic NEN G2 with positive ACTH immunostaining as well. We looked for a correlation between gender-affirming hormone treatment and the onset of the disease and its rapid progression. This may be the first case describing the coexistence of gastrinoma and ectopic Cushing disease in a transsexual patient.<\/jats:p>","DOI":"10.3389\/fendo.2023.1135016","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:40:59Z","timestamp":1678948859000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Severe ectopic Cushing syndrome in a transgender man with a metastatic gastrinoma and an adrenal tumor\u2014A case report and review of the literature"],"prefix":"10.3389","volume":"14","author":[{"given":"Arnika","family":"Wydra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Cylke-Falkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Czajka-Oraniec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Kolasi\u0144ska-\u0106wik\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaros\u0142aw","family":"\u0106wik\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"Zgliczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Stelmachowska-Bana\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i35.5890","article-title":"Gastrinoma and zollinger Ellison syndrome: A roadmap for the management between new and old therapies","volume":"27","author":"Rossi","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5603\/EP.a2022.0051","article-title":"Gastroduodenal neuroendocrine neoplasms including gastrinoma - update of the diagnostic and therapeutic guidelines (recommended by the polish network of neuroendocrine tumours) [Nowotwory neuroendokrynne zoladka i dwunastnicy z uwzglednieniem gastrinoma - uaktualnione zasady postepowania (rekomendowane przez polska siec guzow neuroendokrynnych)]","volume":"73","author":"Rydzewska","year":"2022","journal-title":"Endokrynol Pol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and zollinger-Ellison syndrome: A prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Med (Baltimore)."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-19-0877","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198607033150101","article-title":"Cushing's syndrome in patients with the zollinger-Ellison syndrome","volume":"315","author":"Maton","year":"1986","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1159\/000098009","article-title":"Gastrinoma (duodenal and pancreatic)","volume":"84","author":"Jensen","year":"2006","journal-title":"Neuroendocrinology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ecl.2018.04.009","article-title":"Gastrinomas: Medical or surgical treatment","volume":"47","author":"Norton","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0b013e328365efb1","article-title":"Zollinger-Ellison syndrome: Recent advances and controversies","volume":"29","author":"Ito","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and survival in patients with zollinger-Ellison syndrome: a prospective long-term study","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.2.615","article-title":"Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing zollinger-Ellison syndrome","volume":"17","author":"Yu","year":"1999","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.3.229","article-title":"Cushing's syndrome from ectopic production of corticotropin by a metastatic gastrinoma","volume":"9","author":"Babu","year":"2003","journal-title":"Endocr Pract"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.endinu.2018.02.001","article-title":"Ectopic cushing syndrome: Report of 9 cases","volume":"65","author":"Araujo Castro","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","article-title":"The north American neuroendocrine tumor society consensus paper on the surgical management of pancreatic neuroendocrine tumors","volume":"49","author":"Howe","year":"2020","journal-title":"Pancreas"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.12.6193","article-title":"Prevalence and causes of hypergastrinemia in primary hyperparathyroidism: A prospective study","volume":"84","author":"Corleto","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: Evidence and methodological considerations","volume":"39","author":"Braun","year":"2017","journal-title":"Epidemiol Rev"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-1038","article-title":"A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones","volume":"164","author":"Asscheman","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2019.02.005","article-title":"Cancer risk in transgender people","volume":"48","author":"de Blok","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/10.suppl_4.S131","article-title":"Other risk factors for pancreatic cancer: Hormonal aspects","author":"Andren-Sandberg","year":"1999","journal-title":"Ann Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2020.02.010","article-title":"Pancreatic neuroendocrine neoplasms: Does sex matter","volume":"31","author":"Muscogiuri","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13324","article-title":"Is estrogen exposure a protective factor for pancreatic neuroendocrine tumours in female patients with multiple endocrine neoplasia syndrome type 1","volume":"86","author":"Qiu","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/jhbp.47","article-title":"Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification","volume":"21","author":"Tsutsumi","year":"2014","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001273","article-title":"Risk and predictors of postoperative morbidity and mortality after pancreaticoduodenectomy for pancreatic neuroendocrine neoplasms: A comparative study with pancreatic ductal adenocarcinoma","volume":"48","author":"Partelli","year":"2019","journal-title":"Pancreas"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1845651","article-title":"Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes","volume":"22","author":"Ito","year":"2021","journal-title":"Expert Opin Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1234-1","article-title":"Mechanism of acid hypersecretion post curative gastrinoma resection","volume":"56","author":"Ojeaburu","year":"2011","journal-title":"Dig Dis Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.03.304","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Pavel","year":"2020","journal-title":"Ann Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000340","article-title":"ACTH-secreting pancreatic neoplasms associated with cushing syndrome: Clinicopathologic study of 11 cases and review of the literature","volume":"39","author":"Maragliano","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00129","article-title":"Neuropsychiatric disorders in cushing's syndrome","volume":"9","author":"Pivonello","year":"2015","journal-title":"Front Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12046","article-title":"The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET)","volume":"78","author":"Kanakis","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s12020-016-1127-y","article-title":"Frequency of cushing's syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center","volume":"55","author":"Falhammar","year":"2017","journal-title":"Endocrine."},{"key":"B32","first-page":"101200JCO2201013","article-title":"A Randomized study of temozolomide or temozolomide and capecitabine in patients with advanced pancreatic neuroendocrine tumors (ECOG-ACRIN E2211)","author":"Kunz","year":"2022","journal-title":"J Clin Oncol"},{"key":"B33","doi-asserted-by":"crossref","DOI":"10.1210\/js.2018-00086","article-title":"Severe cushing syndrome due to an ACTH-producing pheochromocytoma: A case presentation and review of the literature","volume":"2","author":"Gabi","year":"2018","journal-title":"J Endocr Soc"},{"key":"B34","first-page":"4869467","article-title":"Adrenal adenoma anarchy: A case of an ACTH-secreting pheochromocytoma","volume":"2020","author":"Lee","year":"2020","journal-title":"Case Rep Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1135016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:41:04Z","timestamp":1678948864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1135016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,16]]},"references-count":34,"alternative-id":["10.3389\/fendo.2023.1135016"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1135016","relation":{},"ISSN":["1664-2392"],"issn-type":[{"type":"electronic","value":"1664-2392"}],"subject":[],"published":{"date-parts":[[2023,3,16]]},"article-number":"1135016"}}